Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2010
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2339667C Method of using tetracycline compounds to enhance interleukin-10 production
05/14/2010WO2010054326A2 C-terminal fragments of glucagon-like peptide-1 (glp-1)
05/14/2010WO2010054324A2 Methods for treating clinical conditions associated with lipoprotein lipase activity
05/14/2010WO2010054267A1 Immunosuppression compound and treatment method
05/14/2010WO2010054260A1 Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054253A1 Triazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054248A1 Trans-clomiphene for metabolic syndrome and diabetes mellitus type 2
05/14/2010WO2010054229A1 Quinoxaline-based lxr modulators
05/14/2010WO2010054001A2 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
05/14/2010WO2010053861A2 Biologically active amides
05/14/2010WO2010053829A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
05/14/2010WO2010053471A1 Modulators of atp-binding cassette transporters
05/14/2010WO2010053165A1 Vitamin d3 lactam derivative
05/14/2010WO2010052847A1 Concentrated liquid diet
05/14/2010WO2010052563A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/14/2010WO2010052310A1 Alpha-lipoic acid derivatives and their use in drug preparation
05/14/2010WO2010052144A2 Neuropeptide-2-receptor (y-2r) agonists and uses thereof
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010010531A3 Composition for controlling increase in blood glucose
05/14/2010WO2010005565A3 Method of treating glycogen storage disease
05/14/2010WO2009156484A3 Organic compounds
05/14/2010WO2009145814A9 Pyrimidines and pyridines useful as inhibitors of protein kinases
05/14/2010CA2743026A1 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
05/14/2010CA2742980A1 Modulators of atp-binding cassette transporters
05/14/2010CA2742821A1 Modulators of atp-binding cassette transporters
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742281A1 Immunosuppression compound and treatment method
05/14/2010CA2741921A1 Neuropeptide-2-receptor (y-2r) agonists and uses thereof
05/14/2010CA2741842A1 Concentrated liquid diet
05/14/2010CA2741537A1 Quinoxaline-based lxr modulators
05/13/2010US20100120912 Esters of capsaicinoids as dietary supplements
05/13/2010US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/13/2010US20100120901 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
05/13/2010US20100120888 Atorvastatin strontium salt and pharmaceutical composition comprising same
05/13/2010US20100120886 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
05/13/2010US20100120869 Compounds and methods for pkc theta inhibition
05/13/2010US20100120868 Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
05/13/2010US20100120864 2-aminooxazolines as taar1 ligands
05/13/2010US20100120863 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/13/2010US20100120861 Benzoic acid inhibitors of atp-sensitive potassium channels
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120790 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity
05/13/2010US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/13/2010US20100120783 Melanocortin receptor agonists
05/13/2010US20100120779 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/13/2010US20100120778 Quinoxaline-based lxr modulators
05/13/2010US20100120775 Farnesoid X Receptor Agonists
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120748 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
05/13/2010US20100120747 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
05/13/2010US20100120743 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
05/13/2010US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
05/13/2010US20100120711 Ampk potentiator containing chito-oligosaccharide
05/13/2010US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof
05/13/2010US20100120682 Compositions for increasing body weight, use and methods
05/13/2010US20100120674 Insulin resistance improving agents
05/13/2010US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
05/13/2010US20100120662 Glucose uptake modulator and method for treating diabetes or diabetic complications
05/13/2010US20100120661 Heterocyclic boronic acid compounds
05/13/2010US20100120660 Highly concentrated insulin solutions and compositions
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119607 Bioenhanced compositions
05/13/2010US20100119595 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents
05/13/2010US20100119559 Dosage forms of risedronate
05/13/2010US20100119517 Use of Anti-MAdCAM Antibodies for the Treatment of Coeliac Disease and Tropical Sprue
05/13/2010US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/13/2010US20100119489 Stimulation of Pancreatic Beta Cell Proliferation
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2184277A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
05/12/2010EP2184062A1 Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
05/12/2010EP2184059A2 Ion binding polymers and uses thereof
05/12/2010EP2184055A1 Process for preparing solid dosage forms of rosiglitazone maleate
05/12/2010EP2183247A1 New crystalline forms of 2 -hydroxy- 3- ý5- (morpholin- 4- ylmethyl) pyridin-2-yl¨ih- indole- 5 -carbonitrile citrate
05/12/2010EP2183237A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183214A1 Crystalline teglicar
05/12/2010EP2182935A1 The use of benzamide derivatives for the treatment of cns disorders
05/12/2010EP2182817A1 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
05/12/2010EP2078001B1 Diazepane-acetamide derivatives as selective 11 -hsd1 inhibitors
05/12/2010EP1971605B1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators
05/12/2010DE202007019054U1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof
05/12/2010CN1973671B Production process of microwave modified oat fiber powder
05/12/2010CN1965813B Compound soft capsule of propolis
05/12/2010CN1951402B Method for preparing active polypeptide and zinc protein of sea cucumber
05/12/2010CN1939895B Compound, composition and method for preventing from neurodegeneration in injury of central nervous system
05/12/2010CN1927050B DHA microcapsule food additives, DHA soft capsule health product and uses thereof
05/12/2010CN1915992B Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
05/12/2010CN1907386B Chinese traditional medicinal composition for treating hyperlipemia, hypertension, and coronary disease
05/12/2010CN1899352B Chinese medicine effective part composition for supplementing qi and recovering pulse
05/12/2010CN1899324B Ginkgo Armillaria mellea oral preparation and its preparing method
05/12/2010CN1895393B Health-care composition for regulating blood fat
05/12/2010CN1895239B Curcumin preparation and its making method
05/12/2010CN1895096B Application of lonicera edulis L and vaccihium vliginosum in preparation of drink for treating diabetes
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 1298